Silvia Requena

420 total citations
17 papers, 220 citations indexed

About

Silvia Requena is a scholar working on Infectious Diseases, Epidemiology and Molecular Biology. According to data from OpenAlex, Silvia Requena has authored 17 papers receiving a total of 220 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Infectious Diseases, 6 papers in Epidemiology and 5 papers in Molecular Biology. Recurrent topics in Silvia Requena's work include HIV Research and Treatment (5 papers), Hepatitis C virus research (5 papers) and HIV/AIDS drug development and treatment (5 papers). Silvia Requena is often cited by papers focused on HIV Research and Treatment (5 papers), Hepatitis C virus research (5 papers) and HIV/AIDS drug development and treatment (5 papers). Silvia Requena collaborates with scholars based in Spain and United Kingdom. Silvia Requena's co-authors include Carmen de Mendoza, Ana Arias, Laura Benítez‐Gutiérrez, Vincent Soriano, Gema M. Lledó, Valentín Cuervas‐Mons, Itzíar Carrasco, Pablo Barreiro, Ana Royuela and Francisco Sánchez‐Madrid and has published in prestigious journals such as Cellular and Molecular Life Sciences, Frontiers in Immunology and AIDS.

In The Last Decade

Silvia Requena

17 papers receiving 217 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Silvia Requena Spain 8 94 84 83 59 36 17 220
Chiara Taibi Italy 8 165 1.8× 58 0.7× 138 1.7× 61 1.0× 38 1.1× 36 262
Sung Hyun Ahn South Korea 9 211 2.2× 44 0.5× 153 1.8× 12 0.2× 44 1.2× 18 263
Malte B. Monin Germany 9 70 0.7× 40 0.5× 23 0.3× 55 0.9× 67 1.9× 21 191
Jamie Frankish Germany 4 123 1.3× 38 0.5× 93 1.1× 11 0.2× 34 0.9× 6 181
Lorenzo Piermatteo Italy 9 137 1.5× 75 0.9× 125 1.5× 11 0.2× 29 0.8× 26 225
Timothy G. Wanninger United States 5 36 0.4× 36 0.4× 21 0.3× 58 1.0× 48 1.3× 9 117
Surekha Tennakoon Australia 9 106 1.1× 112 1.3× 23 0.3× 180 3.1× 35 1.0× 13 326
Mathieu Lefèvre France 6 177 1.9× 26 0.3× 194 2.3× 21 0.4× 71 2.0× 7 299
Leontina Bănică Romania 9 74 0.8× 74 0.9× 10 0.1× 37 0.6× 35 1.0× 22 213
Fengchao Xu China 12 289 3.1× 45 0.5× 244 2.9× 18 0.3× 86 2.4× 22 410

Countries citing papers authored by Silvia Requena

Since Specialization
Citations

This map shows the geographic impact of Silvia Requena's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Silvia Requena with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Silvia Requena more than expected).

Fields of papers citing papers by Silvia Requena

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Silvia Requena. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Silvia Requena. The network helps show where Silvia Requena may publish in the future.

Co-authorship network of co-authors of Silvia Requena

This figure shows the co-authorship network connecting the top 25 collaborators of Silvia Requena. A scholar is included among the top collaborators of Silvia Requena based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Silvia Requena. Silvia Requena is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Martínez‐Fleta, Pedro, Silvia Requena, Pilar Martı́n, et al.. (2024). Cytosolic protein translation regulates cell asymmetry and function in early TCR activation of human CD8+ T lymphocytes. Frontiers in Immunology. 15. 1411957–1411957. 1 indexed citations
2.
Chichón, Francisco Javier, Alessia Ferrarini, Enrique Calvo, et al.. (2023). Chaperonin CCT controls extracellular vesicle production and cell metabolism through kinesin dynamics. Journal of Extracellular Vesicles. 12(6). e12333–e12333. 6 indexed citations
3.
Requena, Silvia, et al.. (2023). End-binding protein 1 regulates the metabolic fate of CD4+ T lymphoblasts and Jurkat T cells and the organization of the mitochondrial network. Frontiers in Immunology. 14. 1197289–1197289. 1 indexed citations
4.
Requena, Silvia, et al.. (2023). Activation kinetics of regulatory molecules during immunological synapse in T cells. Methods in cell biology. 178. 149–171. 4 indexed citations
5.
Martínez‐Fleta, Pedro, Silvia Requena, Emilia Roy‐Vallejo, et al.. (2022). A Differential Signature of Circulating miRNAs and Cytokines Between COVID-19 and Community-Acquired Pneumonia Uncovers Novel Physiopathological Mechanisms of COVID-19. Frontiers in Immunology. 12. 815651–815651. 34 indexed citations
6.
Rodrı́guez, Cristina, Laia Cañes, Alicia Vara, et al.. (2022). CD69-oxLDL ligand engagement induces Programmed Cell Death 1 (PD-1) expression in human CD4 + T lymphocytes. Cellular and Molecular Life Sciences. 79(8). 468–468. 12 indexed citations
7.
Requena, Silvia, Francisco Sánchez‐Madrid, & Noa B. Martín‐Cófreces. (2021). Post-translational modifications and stabilization of microtubules regulate transport of viral factors during infections. Biochemical Society Transactions. 49(4). 1735–1748. 4 indexed citations
8.
Requena, Silvia, Estrella Caballero, Ana Belén Peinado Lozano, et al.. (2019). Treatment outcome in dually HIV-1 and HIV-2 coinfected patients living in Spain. AIDS. 33(14). 2167–2172. 8 indexed citations
9.
Lledó, Gema M., Laura Benítez‐Gutiérrez, Ana Arias, et al.. (2019). Benefits of Hepatitis C Cure With Antivirals: Why Test and Treat?. Future Microbiology. 14(5). 425–435. 3 indexed citations
10.
Benítez‐Gutiérrez, Laura, Vincent Soriano, Silvia Requena, et al.. (2018). Treatment and prevention of HIV infection with long-acting antiretrovirals. Expert Review of Clinical Pharmacology. 11(5). 507–517. 36 indexed citations
11.
Lledó, Gema M., Itzíar Carrasco, Laura Benítez‐Gutiérrez, et al.. (2018). Regression of liver fibrosis after curing chronic hepatitis C with oral antivirals in patients with and without HIV coinfection. AIDS. 32(16). 2347–2352. 46 indexed citations
12.
Requena, Silvia, Ana Treviño, Teresa Cabezas, et al.. (2017). Drug resistance mutations in HIV-2 patients failing raltegravir and influence on dolutegravir response. Journal of Antimicrobial Chemotherapy. 72(7). 2083–2088. 21 indexed citations
13.
Mendoza, Carmen de, Teresa Cabezas, Estrella Caballero, et al.. (2017). HIV type 2 epidemic in Spain. AIDS. 31(10). 1353–1364. 18 indexed citations
14.
Carrasco, Itzíar, Ana Arias, Laura Benítez‐Gutiérrez, et al.. (2017). Baseline NS5A resistance associated substitutions may impair DAA response in real‐world hepatitis C patients. Journal of Medical Virology. 90(3). 532–536. 18 indexed citations
15.
Mendoza, Carmen de, Silvia Requena, Estrella Caballero, et al.. (2017). Antiretroviral Treatment of HIV-2 Infection. Future Virology. 12(8). 461–472. 3 indexed citations
16.
Benítez‐Gutiérrez, Laura, Carmen de Mendoza, Ana Arias, et al.. (2016). Drug-Induced Lung Injury in a Liver Transplant Patient Treated With Sofosbuvir. Transplantation Proceedings. 48(7). 2515–2518. 1 indexed citations
17.
Esposito, Isabella, Laura Benítez‐Gutiérrez, Ana Treviño, et al.. (2016). Impact of ITPA Gene Polymorphisms on the Risk of Ribavirin-Induced Haemolytic Anaemia using Interferon-Free Antivirals for Chronic Hepatitis C. Antiviral Therapy. 22(7). 571–575. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026